Form 4: Bio-Techne Director Exercises Options and Sells Shares
SEC Form 4
Robert V. Baumgartner, a director at Bio-Techne Corp, exercised stock options and sold 16,000 shares of common stock on August 8, 2024.
Summary
- On August 8, 2024, Robert V. Baumgartner, a director of Bio-Techne Corp, exercised stock options to acquire 16,000 shares of common stock at a price of $22.95 per share.
- Simultaneously, Baumgartner sold 16,000 shares of common stock at a weighted average price of $72.104 per share, with individual sales ranging from $72.00 to $72.33.
- Following these transactions, Baumgartner directly owns 43,401 shares of Bio-Techne Corp common stock.
- Baumgartner also holds various stock options with exercise prices ranging from $21.84 to $128.81, expiring between 2025 and 2033.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency regarding the actions of company directors.
Comparison to Industry Standards
- Insider transactions are a normal part of corporate governance and are regularly disclosed by executives and directors in publicly traded companies.
- Comparing Baumgartner's transactions to those of other directors in similar biotech companies would require analyzing their Form 4 filings.
- The size and frequency of these transactions can vary widely depending on individual circumstances and company policies.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the director's sale of shares.
- The impact is likely minimal as it involves a relatively small portion of the company's outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 10/30/2014 | Original grant date of some stock options exercised |
| 10/29/2016 | Grant date of some stock options |
| 10/26/2017 | Grant date of some stock options |
| 10/25/2018 | Grant date of some stock options |
| 10/24/2019 | Grant date of some stock options |
| 10/24/2020 | Grant date of some stock options |
| 10/28/2021 | Grant date of some stock options |
| 10/27/2022 | Grant date of some stock options |
| 10/26/2023 | Grant date of some stock options |
| 08/08/2024 | Date of stock option exercise and share sale |
| 08/12/2024 | Date of Form 4 filing |
| 10/28/2025 | Expiration date of some stock options |
| 10/26/2026 | Expiration date of some stock options |
| 10/26/2027 | Expiration date of some stock options |
| 10/25/2028 | Expiration date of some stock options |
| 10/24/2029 | Expiration date of some stock options |
| 10/29/2030 | Expiration date of some stock options |
| 10/28/2031 | Expiration date of some stock options |
| 10/27/2032 | Expiration date of some stock options |
| 10/26/2033 | Expiration date of some stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.